Effect of exogenous surfactant on Paediatric Bronchoalveolar lavage derived macrophages' cytokine secretion

Lyné van Rensburg1, Johann M van Zyl2, Johan Smith3

  • 1Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences Stellenbosch University, PO Box 241, 8000; Francie van Zijl Drive, Cape Town, Tygerberg, 7505, South Africa.

BMC Pulmonary Medicine
|December 7, 2019
PubMed

Insights

Exogenous surfactant treatment may reduce airway inflammation in children. This study found lower inflammatory cytokines and increased IL-10 and IL-12 levels in bronchoalveolar lavage fluid after surfactant exposure in healthy South African children.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Cellular Immunology

Background:

  • Bronchoalveolar lavage (BAL) is a key bronchoscopy tool, but data from healthy children are scarce.
  • Limited research exists on the anti-inflammatory impact of exogenous pulmonary surfactants on BAL cellular components.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of exogenous surfactants on BAL fluid.
  • To analyze alveolar macrophages and cytokine/chemokine levels in healthy South African children.

Main Methods:

  • Diagnostic bronchoscopy and BAL performed on 30 children (3-14 years).
  • Differential cytology and cytokine/chemokine measurements conducted post-exogenous surfactant exposure.
  • Focus on healthy South African children.

Main Results:

  • Alveolar macrophages were the primary cell type in healthy children's BAL.
  • BAL fluid from inflamed lungs showed significantly higher neutrophil counts.
  • Exogenous surfactant exposure reduced inflammatory cytokine levels and increased IL-10 and IL-12 secretion.

Conclusions:

  • First BAL data presented for healthy South African children.
  • Pulmonary inflammation in children is associated with neutrophilia.
  • Exogenous surfactant therapy shows potential for reducing tracheobronchial inflammation.
Abstract